Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04276051 · ClinicalTrials.gov registry record · NA

Cryovagotomy Diabetes Trial

A NA study of Obesity and Diabetes Mellitus, sponsored by Emory University.

Completed
Registry status
NA
Development phase
5
Enrollment target
5
Study locations

NCT04276051: Completed NA study of Obesity and Diabetes Mellitus, sponsored by Emory University.

NCT04276051 is a NA study of Obesity and Diabetes Mellitus that has completed, run by Emory University. The registered enrollment target is 5 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (99% lower). The trial reports 5 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04276051, a NA study of Obesity and Diabetes Mellitus, has completed, sponsored by Emory University.

COMPLETED
Registry status
NA
Development phase
5 participants
Enrollment target
5
Study locations

Study Summary

The pilot study will assess the feasibility and efficacy of cryoablation procedure to freeze the vagus nerve in obese patients with type 2 diabetes. Aim 1 will focus on changes in glycemic control. Aim 2 will evaluate differences in body weight and anthropometric measurements. This study will provide much needed data for a novel therapeutic intervention to manage obese patients with type 2 diabetes.

Primary Outcome

The hemoglobin A1c test result reflects average blood sugar level for the past two to three months. Specifically, the A1c test measures what percentage of hemoglobin is coated with sugar (glycated). The higher A1c level, the poorer blood sugar control and the higher risk of diabetes complications.

Interventions

  • BEHAVIORAL Lifestyle Intervention
  • DEVICE Cryoablation of the Vagus Nerve

Study Locations (5)

Georgia

  • Emory University Hospital Midtown - Atlanta
  • Emory University Hospital - Atlanta
  • Grady Health System - Atlanta
  • The Emory Clinic - Atlanta
  • Emory Johns Creek Hospital - Johns Creek

Trial Details

FieldValue
Enrollment Target 5 participants
Start Date 2020-10-23
Est. Completion 2022-02-08
Phase NA
Emory University

1,208 total trials

What the finished NCT04276051 record still lists

NCT04276051 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 5 participants, a relatively small participant target, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (99% lower).

The record links to 3 conditions, with Obesity appearing as the primary indexed condition, and to 2 interventions - of which Lifestyle Intervention is the first listed.

NCT04276051 lists 5 locations in 1 state (Georgia).

Frequently Asked Questions

What is clinical trial NCT04276051 about?

NCT04276051 is a clinical study titled "Cryovagotomy Diabetes Trial". The pilot study will assess the feasibility and efficacy of cryoablation procedure to freeze the vagus nerve in obese patients with type 2 diabetes. Aim 1 will focus on changes in glycemic control. Aim 2 will evaluate differences in body weight and anthropometric measurements. This study will provid...

What is the current status of trial NCT04276051?

This trial is currently completed. It is a NA study. The enrollment target is 5 participants. The study started on 2020-10-23. Estimated completion is 2022-02-08.

What conditions does trial NCT04276051 study?

This clinical trial studies the following conditions: Obesity, Diabetes Mellitus, Diabetes Type 2.

What interventions are being tested in trial NCT04276051?

The interventions under investigation include: Lifestyle Intervention (BEHAVIORAL), Cryoablation of the Vagus Nerve (DEVICE).

Who is sponsoring clinical trial NCT04276051?

This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04276051 being conducted?

This trial has 5 study locations across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Obesity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT04276051's enrollment target sits among peer trials

5 1050th of 1053 higher than 1 of 1,053 other Obesity trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Obesity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04276051, the US trial registry maintained by the National Library of Medicine. NCT04276051 (small enrollment · multi site footprint · completed) retrieved and formatted by PlainTrial, see methodology.